Delivery Order SPE2DB20D3104-SPE2DB25FV4Q0

Award Date 1/13/25
Potential Completion Date 1/14/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,090.98, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 14, 2024. The contract is for the delivery of 4,566,722,945 units of the medication Celecoxib 200 mg capsules, with a completion date of December 16, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Celecoxib 200 mg capsules. The contract has a ceiling value of $20,786.08 and a completion date of September 11, 2024. It is a firm-fixed-price contract with no set-aside designation. Amerisourcebergen, through its extensive supply chain network, will provide this prescription medication to support military treatment facilities,...
This federal contract award, valued at $1,401.22, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award covers the delivery of 4554758291 - Celecoxib 200 mg Capsules, in packages of 500, with an ultimate completion date of September 14, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of 4,564,452,271 units of Celebrex 200 mg capsules. The contract has a ceiling value of $4,255.30 and a period of performance ending on May 1, 2024. It is a firm fixed-price contract awarded on a full and open competition basis without any set-aside designations. Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,619.93 firm fixed price delivery order is for the supply of 100 milligram Celebrex capsules. This order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through...
This contract award is for the delivery of 4,564,658,933 units of celecoxib 200mg capsules to the U.S. Defense Logistics Agency (DLA). The contract, valued at $5,562.03, was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical supplier to the federal government. The delivery order is a firm fixed-price contract with a completion date of May 21, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $302,205.40 contract is for the delivery of Celecoxib 200mg tablets to support military and federal healthcare programs. The award is a delivery order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award, valued at $3,558.17, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the delivery of 4,565,938,793 units of Celecoxib 100 mg capsules, a pharmaceutical product, to support various government healthcare programs and federal facilities. This award is not designated as a set-aside contract. AmerisourceBergen, a major pharmaceutical distributor, has been...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,716.28 firm fixed price delivery order is for the supply of 4,563,142,772 units of the pharmaceutical product Celecoxib 400 mg capsules. The contract has a completion date of December 20, 2023. Amerisourcebergen Drug Corp has received numerous similar...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract, valued at up to $10,857.00, is for the delivery of CELEBREX 200 MG CAPSULE 100S, a prescription medication. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of June 21, 2024. This award is not associated with a...
  • SPE2DB20D3104
    Indefinite Delivery Contract
  • SPE2DB20D3104-SPE2DB25FV4Q0
    Delivery Order

This federal contract award, with an ID of SPE2DB20D3104|SPE2DB25FV4Q0, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,914,861 units of the medication Celecoxib 200 mg capsules.

The contract has a ceiling value of $1,092.24 and is a Firm Fixed Price Delivery Order, with a period of performance ending on January 14, 2025. The contract was awarded on January 13, 2025 and was not designated as a set-aside contract.

AmerisourceBergen Drug Corp is a for-profit organization that specializes in distributing a comprehensive range of pharmaceutical products, medical supplies, and equipment to federal government agencies, particularly the military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a wide array of critical medical commodities to support military healthcare programs globally.

Generated 4/14/25, 10:27 AM